tiprankstipranks
Cyclo Therapeutics (CYTH)
NASDAQ:CYTH
US Market

Cyclo Therapeutics (CYTH) Income Statement

Compare
236 Followers

Cyclo Therapeutics Income Statement

Last quarter (Q3 2024), Cyclo Therapeutics's total revenue was $233.77K, a decrease of -52.82% from the same quarter last year. In Q3, Cyclo Therapeutics's net income was $-8.83M. See Cyclo Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.08M$ 1.38M$ 1.59M$ 903.38K$ 1.01M
Gross Profit
$ 977.95K$ 1.24M$ 1.43M$ 836.98K$ 931.71K
Operating Expenses
$ 21.04M$ 16.85M$ 15.70M$ 9.80M$ 8.32M
Depreciation and Amortization
$ 19.28K$ 19.48K$ 16.83K$ 12.76K$ 5.68K
EBITDA
$ -20.03M$ -15.60M$ -14.27M$ -8.95M$ -7.39M
Operating Income
$ -20.05M$ -15.61M$ -14.27M$ -8.96M$ -7.39M
Other Income/Expenses
$ -7.25K$ 171.00K$ 3.40K$ 19.80K$ 12.03K
Pretax Income
$ -20.06M$ -15.45M$ -14.29M$ -8.94M$ -7.53M
Net Income
$ -20.06M$ -15.28M$ -14.31M$ -8.92M$ -7.67M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.23$ -1.81$ -2.25$ -5.58$ -7.09
Diluted EPS
$ -1.23$ -1.81$ -2.25$ -5.58$ -7.09
Weighted Average Shares Outstanding
16.33M 8.44M 6.37M 1.60M 1.08M
Weighted Average Shares Outstanding (Diluted)
16.33M 8.44M 6.37M 1.60M 1.08M
Currency in USD

Cyclo Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis